Combination of | |
---|---|
Imipenem | Carbapenem antibiotic |
Cilastatin | Dehydropeptidase inhibitor |
Clinical data | |
Trade names | Primaxin, Tienam, Cilasafe, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a605011 |
Routes of administration | IV, IM |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
(verify) |
Imipenem/cilastatin, sold under the brand name Primaxin among others, is an antibiotic useful for the treatment of a number of bacterial infections.[1] It is made from a combination of imipenem and cilastatin.[1] Specifically it is used for pneumonia, sepsis, endocarditis, joint infections, intra-abdominal infections, and urinary tract infections.[1] It is given by injection into a vein or muscle.[1]
Common side effects include nausea, diarrhea, and pain at the site of injection.[1] Other side effects may include Clostridium difficile diarrhea and allergic reactions including anaphylaxis.[1] It is unclear if use during pregnancy is safe for the baby.[2] Imipenem is in the carbapenem family of medications and works by interfering with the bacteria's cell wall.[1] Cilastatin blocks the activity of dehydropeptidase I which prevents the breakdown of imipenem.[1]
Imipenem/cilastatin was first sold in 1987.[3] It is on the World Health Organization's List of Essential Medicines.[4]